Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.305 NOK -0.76% Market Closed
Market Cap: 515.6m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Wall Street
Price Targets

HBC Price Targets Summary
Hofseth Biocare ASA

There are no price targets for HBC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hofseth Biocare ASA Competitors:
Price Targets
XOMA
XOMA Corp
156% Upside
AMGN
Amgen Inc
22% Upside
SANA
Sana Biotechnology Inc
348% Upside
NBIX
Neurocrine Biosciences Inc
31% Upside
STRO
Sutro Biopharma Inc
371% Upside
NTLA
Intellia Therapeutics Inc
296% Upside
VCYT
Veracyte Inc
2% Upside
301207
Hualan Biological Bacterin Inc
55% Upside

Revenue
Forecast

Revenue Estimate
Hofseth Biocare ASA

For the last 8 years the compound annual growth rate for Hofseth Biocare ASA's revenue is 17%. The projected CAGR for the next 8 years is -5%.

17%
Past Growth
-5%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Hofseth Biocare ASA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Hofseth Biocare ASA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HBC's stock price target?
Not Available

HBC doesn't have any price targets made by Wall Street professionals.

What is Hofseth Biocare ASA's Revenue forecast?
Projected CAGR
-5%

For the last 8 years the compound annual growth rate for Hofseth Biocare ASA's revenue is 17%. The projected CAGR for the next 8 years is -5%.

Back to Top